Tsuyoshi Hirota. Interrogating circadian clock compounds as an adjuvant to chemoradiation against GBM. Cancer Research. 2024
Aya Ogata, Takashi Yamada, Saori Hattori, Hiroshi Ikenuma, Junichiro Abe, Mari Tada, Masanori Ichise, Masaaki Suzuki, Kengo Ito, Takashi Kato, et al. Development of a novel PET ligand, [11C]GO289 targeting CK2 expressed in the brain. Bioorganic & medicinal chemistry letters. 2023. 90. 129327-129327
Christian Borgo, Luca Cesaro, Tsuyoshi Hirota, Keiko Kuwata, Claudio D'Amore, Thomas Ruppert, Renata Blatnik, Mauro Salvi, Lorenzo A Pinna. Analysis of the phosphoproteome of CK2α(-/-)/Δα' C2C12 myoblasts compared to the wild-type cells. Open biology. 2023. 13. 2. 220220-220220
Tsuyoshi Hirota. Small molecule circadian clock compounds display therapeutic potential in targeting glioblastoma stem cells. Cancer Research. 2023
Tsuyoshi Hirota. TARGETING THE CIRCADIAN CLOCK WITH SMALL MOLECULE COMPOUNDS RESULTS IN ANTI-TUMOR EFFECTS SPECIFICALLY IN GLIOBLASTOMA STEM CELLS. Neuro-Oncology. 2023